Abstract CCN proteins play crucial roles in development, angiogenesis, cell motility, matrix turnover, proliferation, and other fundamental cell processes. Early embryonic lethality in CCN5 knockout and over-expressing mice led us to characterize CCN5 distribution in early development. Previous papers in this series showed that CCN5 is expressed widely in mice from E9.5 to adult; however, its distribution before E9.5 has not been studied. To fill this gap in our knowledge of CCN5 expression in mammals, RT-PCR was performed on preimplantation murine embryos: 1 cell, 2 cell, 4 cell, early morula, late morula, and blastocyst. CCN5 mRNA was not detected in 1, 2, or 4 cell embryos. It was first detected at the early morula stage and persisted to the preimplantation blastocyst stage. Immunohistochemical staining showed widespread CCN5 expression in postimplantation blastocysts (E4.5), E5.5, E6.5, and E7.5 stage embryos. Consistent with our previous study on E9.5 embryos, this expression was not limited to a particular germ layer or cell type. The widespread distribution of CCN5 in early embryos suggests a crucial role in development.
Introduction
CCN5 is a member of the cysteine-rich 61/connective tissue growth factor/nephroblastoma-overexpressed (CCN) family of genes (Perbal 2005) . The six members of this family are matricellular proteins that have important functions in numerous cell and physiologic processes, including embryonic development, cell motility and proliferation, angiogenesis, and extracellular matrix biology (Leask and Abraham 2006; Perbal 2004; Perbal 2005; Rachfal and Brigstock 2005) . CCN5, also known as WISP-2 (Pennica et al. 1998), rCop-1 (Zhang et al. 1998) , COP-1 (Delmolino et al. 2001) , and CTGF-L (Kumar et al. 1999) , is highly conserved among vertebrates and is the only CCN protein lacking the Cterminal domain (Gray 2005) .
Originally discovered as a heparin-induced gene in vascular smooth muscle cells (SMC), CCN5 behaves as a growth-arrest-specific gene in this cell type. CCN5 is highly expressed in quiescent, non-proliferating rat aortic SMC and expression levels drop rapidly as cells are stimulated to reenter the cell cycle. SMC CCN5 expression decreases in uterine fibroids and after vascular injury, two in vivo models of SMC proliferation (Delmolino et al. 2001; Mason et al. 2004b ). CCN5 over-expression inhibits SMC proliferation and motility in vitro, and CCN5 knockdown dysregulates proliferation and increases basal motility Mason et al. 2004b) . CCN5 is strongly up-regulated by estrogen in both SMC and epithelial cells (Fritah et al. 2006; Inadera et al. 2000; Mason et al. 2004a ).
Efforts to develop transgenic mice overexpressing CCN5 resulted in early embryonic lethality. Further analysis indicated that embryos developed until the blastocyst stage and were implanted, but did not progress beyond this point and appeared to be undergoing resorption. The crucial role of other CCN proteins is also suggested by gene manipulation studies in mice. Targeted deletion of the CCN1 gene in mice resulted in embryonic lethality due to vascular defects (Mo et al. 2002) , whereas CCN2-null mice die perinatally due to respiratory failure (Ivkovic et al. 2003) . Targeted deletion of CCN3 gene is not embryonic lethal in mice. However, it results in abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts (Heath et al. 2008) .
To better understand the role of CCN proteins in preimplantation development, and to complement earlier studies of embryonic expression by our group and others (Jones et al. 2007; Katsube et al. 2001; Pin 2006; Surveyor et al. 1998) , we assessed the onset of CCN5 transcription using real time PCR in preimplantation embryos. These results are reported in this communication and indicate that CCN5 expression begins in early morulae, while CCN2 expression was detected one cell division earlier, at the 4-cell stage.
Materials and methods
Immunohistochemistry 5 μm frozen sagittal sections of C57BL/6 post-implantation embryos were obtained from Folio Bio (Columbus, OH). Sections were cleared with xylene and endogenous peroxidase activity was quenched by treatment with two changes of 0.6 % hydrogen peroxide (H 2 O 2 ) in ethanol for 5 min. The slides were then rehydrated and treated with the Avidin/ Biotin Blocking Kit (Vector Laboratories) in blocking serum (4 % bovine serum albumin and 2 % goat serum in phosphate-buffered saline) and then incubated in primary antibody in blocking serum overnight at 4°C. CCN5 protein was detected using a well characterized, highly specific, peptide affinity-purified rabbit polyclonal antibody to a polypeptide fragment from amino acids 103-117 of the von Willebrand Factor-C (VWC) domain of CCN5 (Gray 2005; Mason et al. 2004a ). This recognizes full-length 27 kDa CCN5 protein on western blot (Gray 2005; Mason et al. 2004a ). Embryos did not immunostain when mixed IgG was used in place of the CCN5 primary antibody. Slides were developed using the Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) and the 3,3'-diaminobenzidine (DAB) substrate kit (Vector Laboratories) and counterstained with Harris modified hematoxylin with acetic acid (Fisher). All slides were dehydrated and embedded in permanent mounting medium (#13510; DPX Mountant; Electron Microscopy Sciences; Hatfield, PA) and photographed using a microscope (Zeiss Axioscope) and a digital camera system (SPOT; Diagnostic Instruments). Antibody concentrations and substrate exposure times were carefully titrated to minimize artifacts. Directly compared images are from slides processed in a single experiment with a matched negative control.
Pre-implantation embryo collection C57BL/6J female mice (approximately 5 weeks old) were superovulated using a 5 IU IP injection of pregnant mare's serum gonadotropin (PMSG) (NIH National Hormone & Peptide Program, Torrance, CA) followed by 5 IU of human chorionic gonadotropin (hCG) (Sigma Aldrich, St. Louis, MO) 48 h later. These females were mated to C57BL/6J males immediately after hCG injection. Pregnant mice were then sacrificed with carbon dioxide (CO 2 ) overdose at various time points depending on the embryo stage desired [1 cell (18 h post hCG injection), 2 cell (42 h), 4 cell (54 h), morula (66 h), late morula (70 h), blastocyst (90 h)]. Oviducts and uterine horns were dissected from the pregnant mice and embryos were collected as described (Nagy 2003) .
mRNA isolation
Messenger RNAs from mouse embryos were extracted by Dynabeads mRNA Direct Micro Kit (Invitrogen, Carlsbad, California) according to the manufacturer's protocol. Briefly, mouse embryo masses were dissociated in 0.3 mg/mL hyaluronidase (Chemicon, Billerica, MA) in M2 media (Chemicon, Billerica, MA) for 2 min. Dissociated embryos were washed 3X in PBS. Fifteen to 30 embryos were transferred with a minimal volume of medium into 100 μL of lysis buffer (100 mM Tris-HCl, pH 7.5; 500 mM LiCl, 10 mM EDTA, 1 % lithium dodecylsulfate [LiDS] , and 5 mM dithiothreitol) and mixed with 20 μL of Dynabeads oligo(dT)25 for 3-5 min. The bound mRNAs were washed twice in washing buffer containing LiDS (10 mM TrisHCl; pH 7.5, 0.15 M LiCl, 1 mM EDTA, and 0.1 % LiDS), then three times in washing buffer (10 mM Tris-HCl, pH 7.5; 0.15 M LiCl, 1 mM EDTA). The bound mRNAs were then resuspended and eluted in 10 μL of 10 μM Tris-HCl at 80°C.
Reverse transcriptase PCR (RT-PCR)
The mRNA isolated from pre-implantation embryos using Dynabeads were reverse transcribed into cDNA using the Retroscript kit (Ambion, Naugatuck, CT) according to their protocol. PCR reactions were made using the iTaq kit (BioRad, Hercules, CA) according to manufacturer's protocol. Primers were as follows: CCN5: GTTGGATACTCGGGTGGCTA and ATACAGGTGCCAGGAAGGTG, CCN2: ATCCGAATTC CAGAACTGCAGCGGGCCGTGCCGGTGCCCG and ATA C G G AT C C C T C AT G C C AT G T C T C C G TA C A TCTTCCTGTHPRT: GCTTGCTGGTGAAAAGGAC CTCTCGAAG and CCCTGAAGTACTCATTATAGTCA AGGGCAT PCR was performed using the following conditions: 94°C for 4 min, (94°C for 30 s, 65°C for 30 s, and 72°C for 1 min) for 35 cycles, then 72°C for 5 min. PCR reactions were then run on a 1 % agarose gel and stained with ethidium bromide.
Results

CCN5 Transcription in Pre-implantation embryos
Our efforts to generate transgenic mice overexpressing CCN5 produced extremely small litter sizes, due to an apparent early embryonic lethality. Following pronuclear injection of overexpression constructs and subsequent dissection of uterine horns, we observed that the transgenic mice developed until the blastocyst stage and were implanted. However, no development past the blastocyst stage was ever observed, and the small number of embryos that were implanted appeared to be undergoing resorption into the decidua. To assess the embryonic stage at which CCN5 transcription begins, we superovulated C57BL/6J female mice and collected 1-cell, 2-cell, 4-cell, early morula (12-16 cell), late morula (32-48 cell), and blastocyst embryos. Total mRNA was extracted from these embryos and reverse transcribed. The resulting cDNA was PCR amplified using primers for CCN5 and then loaded on an agarose gel (Fig. 1) . CCN5 mRNA was not detected in 1-cell, 2-cell, and 4-cell staged embryos. It was first detected in the early morula and persisted through the later morula and blastocyst stages. To compare this expression pattern with CCN2, we used the same embryonic extracts and RT-PCR approach.
CCN2 transcription began slightly earlier than that of CCN5, at the 4-cell stage.
Observations by others indicate that the CCN1 transcript is absent in 1-cell embryos, appears first in 2-cell embryos and remains to the blastocyst stage (Pin 2006). These investigators also found that CCN2 transcript was not consistently present until the 4-cell stage, and then persisted to the blastocyst stage and beyond. Interestingly, Fig. 1 CCN5 mRNA transcription begins at the morula stage of development. C57BL/6 embryos were harvested and pooled as described in Materials and Methods. Total mRNA was extracted and then reverse transcribed. PCR was performed using primers specific to CCN5, CCN2, or HPRT (loading control) Fig. 2 CCN5 is expressed in E4.5 embryos (implanted blastocysts). 5 μm frozen sagittal sections of embryo were processed as described in Materials and Methods. BC 0 Blastocoel; D 0 Decidua; E 0 Endometrium; ICM 0 Inner Cell Mass. Scale Bar 0 50 μm. Brown staining indicates CCN5 immunoreactivity. Nuclei are visualized by hematoxylin (blue) staining these investigators observed transient transcription of CCN3 at the 4-cell and early morula stage, which was not detected by the late morula stage.
CCN5 Expression pattern in post-implantation embryos
We further studied the temporal and spatial pattern of CCN5 expression in post-implantation embryos using a well-characterized anti-CCN5 antibody Mason et al. 2004b ). C57BL/6 embryos (E4.5, E5.5, E6.5, and E7.5) were harvested and prepared as described in Materials and Methods. No color reaction was detected when pooled rabbit IgG replaced primary antibody, corroborating the specificity of the antibody (Jones et al. 2007 ).
Implantation of the blastocyst in the uterine horn occurs at E4.5 (Fig. 2) . CCN5 expression was widespread at this stage. It was present within the extraembryonic maternal cells of both the decidua and endometrium surrounding the implanted blastocyst. We saw continued expression of CCN5 in the decidua in every stage studied (up to E7.5). At least some of the inner cell mass (ICM) cells, which eventually become the embryo proper, expressed CCN5 protein.
Once the embryo reached embryonic stage E5.5 the ICM cells proliferated rapidly, giving rise to the epiblast that subsequently formed the egg cylinder. The cells of the egg cylinder expressed CCN5 (Fig. 3) . The egg cylinder differentiates at E6.5. After formation of the amniotic cavity, gastrulation begins and the first mesoderm cells are evident. At this stage CCN5 continued to display widespread expression, and was not germ layer specific as it was present in all three germ layers: endoderm, mesoderm and ectoderm (Fig. 4) . The widespread expression of CCN5 persisted into stage E7.5 as gastrulation concluded (Fig. 5) .
Discussion
In this study we show that CCN5 transcription initiates at the early morula stage and persists through the pre-and post-implantation embryo stages. The onset of CCN5 transcription at the early morula (12-16 cell) stage is consistent with the onset of a major transcriptional wave that begins at approximately the 4-cell stage in mice (Clegg and Piko 1983) . The CCN5 expression patterns we observed are very similar to those of CCN2 (Surveyor et al. 1998 ). In the newly implanted blastocyst (E4.5), these investigators observed robust CCN2 expression in the inner cell mass, and at Furthermore, we confirm that CCN5 transcription begins later than CCN1, CCN2, and CCN3 in mouse embryos (Table 1) . These data complement the CCN5 expression data in later stage embryos (E9.5 through 18) recently published by our group (Jones et al. 2007) , as well as data on CCN5 expression in adult rodents . With the data provided in this communication, we now have a reasonably complete map of the cell and tissue-specific expression pattern of CCN5 in rodents from the zygote to the adult.
There is a potentially important difference between the transcription initiation points of CCN5 compared to other CCN family members, such as CCN1, CCN2, and CCN3. Prior to the early morula stage, the embryo is a relatively loosely associated group of equal-volume cells that undergo synchronous proliferation. Beginning at the 8-cell stage in mice, compaction begins and with it asymmetric embryo development, characterized by unequal cell volumes, proliferation and migration rates, and positions within the embryonic morula. It is possible that CCN5, a molecule with antiproliferative and antimotility properties, begins transcription at the early morula stage to counteract or balance the effects of the mitogenic and motogenic activities of the other CCN family members.
To date, only the expression patterns of CCN2 and CCN5 have been examined in very early mammalian development (Surveyor et al. 1998) . CCN3 has been studied in early avian development. Robust CCN3 expression is seen in the neuroepithelium (E3) and neural tube (E3-E7) in chick embryos (Katsube et al. 2001) .
There are several pathologic conditions in which CCN2 and CCN5 have inversely coordinated expression patterns, including asthma (unpublished observations; (van den Brule et al. 2007 )) uterine leiomyoma (fibroids) (De Falco et al. 2006; Mason et al. 2004b) , and hepatocellular carcinoma (Cervello et al. 2004; Hirasaki et al. 2001) . However, in other diseases, including arthritis (Manns et al. 2006; Tanaka et al. 2005 ) and viral hepatitis (Fukutomi et al. 2005; Shin et al. 2005 ), CCN2 and CCN5 are similarly expressed. CCN2 and CCN5 demonstrate different biological activity profiles in vascular SMC. CCN2 over-expression induces vascular SMC proliferation and increases MMP-2 expression, whereas CCN5 over-expression reduces proliferation and MMP-2 expression. CCN5 expression decreases and CCN2 expression increases in vascular SMC during the proliferative phase of balloon angioplasty injury (Ando et al. 2004; Fan and Karnovsky 2002; Fan et al. 2000; . We are actively investigating the potential interplay between CCN5, CCN2, and other CCN family members in early development.
Our examination of post-implantation CCN5 expression yielded interesting results. In early post-implantation E4.5 mouse embryos, we observe CCN5 expression in the inner cell mass, which ultimately forms the embryo proper. The observed ICM expression is consistent with our earlier findings that CCN5 is widely expressed within fetal tissues at E8.5 and later. CCN5 was also present within the extraembryonic maternal cells of both the decidua and endometrium surrounding the implanted blastocyst. We see continued expression of CCN5 in the decidua in every stage we studied (up to E7.5). At the E5.5 stage, when the egg cylinder formed, there is robust and ubiquitous expression of CCN5. Between E5.5 and 6.5, the egg cylinder differentiated. After formation of the amniotic cavity, gastrulation began and the first mesoderm cells were evident. At this stage, CCN5 continued to display widespread expression, and was not germ layer specific as it is present in mesoderm, ectoderm, and endoderm. The widespread expression of CCN5 continued through stage E7.5; as gastrulation concluded, CCN5 was found in all three germ layers.
Given the early onset of CCN5 transcription, ubiquitous expression in all three germ layers, and embryonic lethality in both CCN5-null and CCN5 over-expressor mice, CCN5 appears to play a critical role in early embryonic development. Further studies are required to define the mechanisms and specific roles played by CCN5 in this context.
